+634.5%
MRNA vs EQIX
+203.3%
+431.3%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | EQIX | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.7% | -1.8% | +2.6% | +1.5% |
| 7D | -8.2% | -1.6% | -6.6% | -7.6% |
| 30D | +125.6% | -0.4% | +125.9% | +125.3% |
| 3M | +197.1% | -0.9% | +198.0% | +195.9% |
| 6M | +148.5% | +8.1% | +140.4% | +138.2% |
| YTD | +363.3% | +35.7% | +327.6% | +299.4% |
| 1Y | +462.0% | +34.0% | +428.0% | +389.4% |
| 3Y | +26.9% | +41.4% | -14.5% | +6.2% |
| 5Y | -69.6% | +34.0% | -103.6% | -74.7% |
| All | +634.5% | +203.3% | +431.3% | +284.0% |
Cumulative growth
Daily Returns
Daily percentage return beside EQIX.
Daily Out/Under-Performance
Portfolio return minus EQIX return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EQIX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded EQIX wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling